课题基金 / 基金详情

Nonmuscle Myosin II-C and its Isoform

Nonmuscle Myosin II-C and its Isoform
非肌肉肌球蛋白 II-C 及其异构体
批准号:
7158532
负责人:
ROBERT ADELSTEIN
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

ROBERT ADELSTEIN的其他基金

相似基金

相关文献

中文摘要
翻译
本实验室先前的一份报告显示,新发现的非肌肉肌球蛋白重链II-C(NMHC II-C)包含一个由24个核苷酸组成的替代外显子,编码8个氨基酸。该外显子被剪接到NMHC II-C的环I中,存在于各种组织和细胞系中。与未插入的异构体相比,插入该外显子会导致肌动蛋白激活的镁ATPase活性和重链肌球蛋白II-C的体外运动性增加。RT-PCR分析表明,编码插入异构体的mRNA在许多人上皮性肿瘤细胞系中高表达,如肝细胞系HepG2、前列腺细胞系PC-3、胰腺癌细胞系PANC-1、乳腺癌细胞系MCF-7和肺细胞系A-549。有趣的是,当我们量化所有三种非肌肉肌球蛋白亚型(NMHC II-A、II-B和II-C)在肿瘤细胞系和正常细胞系中的表达水平时,插入的II-C在肿瘤细胞系中的表达比正常细胞系高(超过8倍)。相反,通过扫描免疫印迹检测,肿瘤细胞系中NMHC II-A和II-B的数量分别减少了3倍和4倍以上。对人类乳腺、肾脏和肺肿瘤的分析证实,与正常相关组织相比,这三种肿瘤中NMHC II-C的表达都有所增加。用siRNA使A549肺癌细胞系中插入的异构体减少90%,在156 h时抑制生长达80%,这种抑制几乎完全被外源表达的NMHC II-C所恢复,而非插入的II-C只能部分恢复。这些研究表明,NMHC II-C亚型可能在某些上皮性肿瘤细胞系中起作用。
英文摘要
A previous report from this laboratory revealed that the newly recognized nonmuscle myosin heavy chain II-C (NMHC II-C) contains an alternative exon composed of 24 nucleotides encoding 8 amino acids. This exon is spliced into loop I of NMHC II-C and is present in a wide variety of tissues and cell lines. Insertion of this exon leads to an increase in the actin-activated MgATPase activity and in vitro motility of heavy meromyosin II-C compared to the noninserted isoform. RT-PCR analysis reveals that the mRNA encoding the inserted isoform is highly expressed in many human epithelial tumor cell lines such as liver, HepG2; prostate, PC-3; pancreas, PANC-1; breast, MCF-7, and lung, A-549 cells. Interestingly, when we quantitated the expression level of all three nonmuscle myosin isoforms (NMHC II-A, II-B and II-C) in tumor cell lines vs normal cell lines, the expression of inserted II-C was elevated (greater than 8-fold) in the tumor cell lines compared to the normal cell lines. In contrast, NMHC II-A and II-B were decreased (greater than 3- and greater than 4-fold, respectively) in the tumor cell lines as determined by scanning immunoblots. Analysis of breast, kidney and lung tumors from humans confirmed the increase in NMHC II-C expression in all three tumors compared to their normal associated tissue. Using siRNA to reduce the inserted isoform by 90% in the A549 lung epithelial cancer cell line leads to 80% growth inhibition at 156 h. This inhibition of growth was almost completely rescued by exogenous expression of the inserted NMHC II-C, but only partially rescued by noninserted II-C. These studies suggest a putative role for the NMHC II-C isoform in certain epithelial tumor cell lines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EXPRESSION OF NONMUSCLE MYOSIN ISOFORMS IN EUKARYOTIC CELLS
NULL MUTATIONS OF VERTEBRATE NONMUSCLE MYOSIN HEAVY CHAINS
INTERACTION OF NONMUSCLE MYOSIN II WITH PLASMA MEMBRANES
EXPRESSION OF NONMUSCLE MYOSIN ISOFORMS IN EUKARYOTIC CELLS
海外基金